GlaxoSmithKline and Codexis: A Look at the Licensing Agreement

Image via Flickr by e-Magine Art

Codexis is an enzyme producer that develops biocatalysts for the pharmaceutical industry. They have proven technology that reduces the cost of manufacturing drugs through sustainable processes. In July 2014, Codexis signed an agreement with GlaxoSmithKline (GSK) to share a technology license.

This article is for Premium Members only. Please login below to read the rest of this article.

Not a Premium Member yet? Become one today.